A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...
IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.
To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...
The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...
In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback